SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis

被引：23

作者：

Nagao, Mizuho ^{[1
]}

Inagaki, Shinichiro ^{[2
]}

Kawano, Toshiki ^{[3
]}

Azuma, Yoshinori ^{[4
]}

Nomura, Noriko ^{[4
]}

Noguchi, Yasuhiko ^{[4
]}

Ohta, Shoichiro ^{[5
]}

Kawaguchi, Atsushi ^{[6
]}

Odajima, Hiroshi ^{[3
]}

Ohya, Yukihiro ^{[2
]}

Fujisawa, Takao ^{[1
]}

Izuhara, Kenji ^{[5
]}

机构：

[1] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan

[2] Natl Ctr Child Hlth & Dev, Div Allergy, Dept Med Subspecialties, Tokyo, Japan

[3] Fukuoka Natl Hosp, Dept Pediat, Fukuoka, Japan

[4] Shino Test Corp, Sagamihara, Kanagawa, Japan

[5] Saga Med Sch, Div Med Biochem, Dept Biomol Sci, Saga, Japan

[6] Saga Med Sch, Ctr Comprehens Community Med, Saga, Japan

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 05期

关键词：

CELL CARCINOMA ANTIGENS; GUIDELINES; MANAGEMENT; PSORIASIS; SEVERITY;

D O I：

10.1016/j.jaci.2018.01.021

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1934 / +

页数：14

共 50 条

[1] Serum squamous cell carcinoma antigen-2 (SCCA2) is a reliable biomarker for detecting the clinical severity of atopic dermatitis in children
Inagaki, S.
Nagao, M.
Narita, M.
Kawano, T.
Azuma, Y.
Nomura, N.
Noguchi, Y.
Odajima, H.
Fujisawa, T.
Ohya, Y.
Izuhara, K.
ALLERGY, 2018, 73 : 730 - 730
[2] Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis
Kita, Kanako
Imai, Yasutomo
Nagai, Makoto
Natsuaki, Masaru
Kanazawa, Nobuo
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 100 - 101
[3] The usefulness of SCCA2 and periostin as clinical biomarkers for severe adult atopic dermatitis
Fujimoto, R. F.
Kataoka, Y. K.
Kishida, H. K.
Sachiko, S. S.
Shigyou, A. S.
Yoshioka, E. Y.
Tonomura, K. T.
Okuda, E. O.
Izuhara, K. I.
BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E51 - E52
[4] Clinical utility of new biomarkers, periostin and SCCA1/SCCA2, in childhood asthma and atopic dermatitis
Hirayama, J.
Kainuma, K.
Nagao, M.
Fujisawa, T.
Ohta, S.
Izuhara, K.
ALLERGY, 2015, 70 : 55 - 55
[5] Serum TARC and SCCA2 Levels In Infantile Atopic Dermatitis: Associations with Atopy and Severity
Berber, Ilkay Bahar Balaban
Koksal, Zeynep Gulec
Yilmaz, Mustafa
Omurlu, Imran Kurt
Uysal, Pinar
Erge, Duygu
ASTHMA ALLERGY IMMUNOLOGY, 2024, 22 (02): : 153 - 160
[6] SCCA, SCCA1 and SCCA2 in cervical cancer patients
Jan, Kulpa
Rychlik, U.
Jakubowicz, J.
Einarsson, R.
Rusiecka, G.
Sedlaczek, P.
TUMOR BIOLOGY, 2006, 27 : 113 - 113
[7] Biomarker prediction of pediatric atopic dermatitis severity
Kaplan, Mark H.
Engle, Sarah
Chang, Ching-Yun
Satterwhite, Allyson
Ulrich, Benjamin
Hayes, Tristan
Tepper, Robert
Sims, Jonathan
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[8] SCCA, SCCA1, SCCA2 in healthy persons and patients with benign disease
Kanty, Kulpa Jan
Urszula, Rychlik
Ewa, Wojcik
Krzysztof, Reinfuss
Ewa, Misiak
TUMOR BIOLOGY, 2006, 27 : 110 - 110
[9] Inflammation upregulates expression of the intracellular serpins SCCA1 and SCCA2
Cataltepe, S
Fornsaglio, J
Gornstein, ER
Kumar, V
Luke, C
Pak, S
Schick, C
Tsu, C
Uemura, Y
Upton, MP
Silverman, GA
PEDIATRIC RESEARCH, 1999, 45 (04) : 9A - 9A
[10] Inflammation Upregulates Expression of the Intracellular Serpins SCCA1 and SCCA2
Sule Cataltepe
Jamie Fornsaglio
Eric R Gornstein
Vasantha Kumar
Cliff Luke
Stephen Pak
Charles Schick
Christopher Tsu
Yoshiki Uemura
Melissa P Upton
Gary A Silverman
Pediatric Research, 1999, 45 : 9 - 9

← 1 2 3 4 5 →